Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma.

J Hepatocell Carcinoma · 2024 · PMC11162638 · PMID 38854818

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

borderline significancep = 0.072so close (0.05 < p ≤ 0.1)

In patients who received sorafenib, an increase in SV after treatment exhibited borderline significance in predicting poor PFS in multivariate analysis (HR, 1.87; 95% CI, 0.95–3.71, p = 0.072; Table 4 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.